Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
The British Journal of Ophthalmology
|
December 15, 2015
Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study
Margaret A Greven, Sunir Garg, Bing Chiu, et al.
Retina (Philadelphia, Pa.)
|
June 16, 2015
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations
K Bailey Freund, Jean-François Korobelnik, Robert Devenyi, et al.
JAMA Ophthalmology
|
May 31, 2014
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials
Gui-shuang Ying, Benjamin J Kim, Maureen G Maguire, et al.
JAMA Ophthalmology
|
March 6, 2025
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial
Arshad M Khanani, Peter A Campochiaro, Jordan M Graff, et al.
Current Eye Research
|
May 24, 2022
Predictors of Vision Loss after Surgery for Macula-Sparing Rhegmatogenous Retinal Detachment
Anand Gopal, Matthew Starr, Anthony Obeid, et al.
American Journal of Ophthalmology
|
July 17, 2023
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema
Charles C Wykoff, Justus G Garweg, Carl Regillo, et al.
Ophthalmology
|
October 1, 2021
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Nancy M Holekamp, Peter A Campochiaro, Margaret A Chang, et al.
Ophthalmology. Retina
|
November 1, 2023
Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
Saagar A Pandit, Bita Momenaei, Taku Wakabayashi, et al.
Ophthalmology
|
March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Carl Regillo, Brian Berger, Logan Brooks, et al.
Ophthalmology
|
April 5, 2019
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial
Peter A Campochiaro, Dennis M Marcus, Carl C Awh, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
The British Journal of Ophthalmology
|
December 15, 2015
Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study
Margaret A Greven, Sunir Garg, Bing Chiu, et al.
Retina (Philadelphia, Pa.)
|
June 16, 2015
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations
K Bailey Freund, Jean-François Korobelnik, Robert Devenyi, et al.
JAMA Ophthalmology
|
May 31, 2014
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials
Gui-shuang Ying, Benjamin J Kim, Maureen G Maguire, et al.
JAMA Ophthalmology
|
March 6, 2025
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial
Arshad M Khanani, Peter A Campochiaro, Jordan M Graff, et al.
Current Eye Research
|
May 24, 2022
Predictors of Vision Loss after Surgery for Macula-Sparing Rhegmatogenous Retinal Detachment
Anand Gopal, Matthew Starr, Anthony Obeid, et al.
American Journal of Ophthalmology
|
July 17, 2023
KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema
Charles C Wykoff, Justus G Garweg, Carl Regillo, et al.
Ophthalmology
|
October 1, 2021
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Nancy M Holekamp, Peter A Campochiaro, Margaret A Chang, et al.
Ophthalmology. Retina
|
November 1, 2023
Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
Saagar A Pandit, Bita Momenaei, Taku Wakabayashi, et al.
Ophthalmology
|
March 4, 2023
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
Carl Regillo, Brian Berger, Logan Brooks, et al.
Ophthalmology
|
April 5, 2019
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial
Peter A Campochiaro, Dennis M Marcus, Carl C Awh, et al.
Page
of 4